£86.27

Springer Bioactive Heterocycles III: 9 (Topics in Heterocyclic Chemistry, 9)

Price data last checked 46 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 45 days • 45 data points (No recent data available)

Historical
Generating forecast...
£87.15 £78.88 £80.68 £82.49 £84.29 £86.10 £87.90 25 January 2026 05 February 2026 16 February 2026 27 February 2026 10 March 2026

Price Distribution

Price distribution over 45 days • 4 price levels

Days at Price
Current Price
19 days 7 days 9 days · current 10 days 0 5 10 14 19 £80 £84 £87 £87 Days at Price

Price Analysis

Most common price: £80 (19 days, 42.2%)

Price range: £80 - £87

Price levels: 4 different prices over 45 days

Description

"Bioactive Heterocycles III" provides readers with a comprehensive overview of the most recent breakthroughs in the ?eld of heterocycles. This volume contains 8 chapters written by experts in their respective ?elds from all over the world. The chapters summarize years of extensive research in each area, andprovideinsightinthenewthemesofnaturalproductresearch.Manyofthe contributors illustrate their laboratory experiences. It's obvious that readers will gain exciting and essential information fromthe volume. In the ?rst chapter, Kayser et al. describe the chemistry, biosynthesis and biological activities of artemisinin, one of the most promising antimalarial molecules, and its related natural peroxides. They present new strategies of producing artemisinin that utilize fascinating technologies. as Additionally, thepharmacokineticpro?leandthedevelopmentofnewdrugdeliverysystems onPlasmodium infected erythrocytesare presented . Khan describes some aspects of sugar-derived heterocycles and their p- cursors which are utilized as the inhibitors against glycogen phosphorylases (GPs), and are responsible for the release of mono-glucose from poly-glucose (glycogen) in the second chapter. The inhibitors of GP could help to stop or slowdownglycogenolysisaswellasglucoseproduction.Ultimately, thewhole processwill result in the recovery fromdiabetes of NIDDMpatients. In his contribution, Verma studies quantitative structure-activityrelati- ship (QSAR) and proposes several interesting QSAR models of heterocyclic molecules having cytotoxicactivities against different cancer cell lines, which couldin turn clarify the chemical-biologicalinteractions ofsuch compounds. Alamgir et al., in the fourth chapter, review the recent progress of the synthesis, reactivity and biological activities of benzimidazoles. Additionally, they describe several new techniques and procedures for the synthesis of the same scaffold. Inthe?fthchapter,KhanreviewstheessentialroleoftheenzymeTyrosinase in human melanin production, covering various related clinical problems.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
26 October 2007
Listed Since
02 July 2007

Barcode

No barcode data available